Tag: Robert F. Apple

March 3, 2020

Antares Pharma Reports Q4 and Full Year 2019 Financial Results

Antares Pharma reported operating and financial results for the fourth quarter and full year ended December 31, 2019.
January 27, 2020

Antares Announces 2020 Revenue Guidance Range of up to US$155 Million

Antares announced its 2020 net revenue guidance of US$135 to US$155 million, which includes potential revenue scenarios for AMAG’s Makena.